Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Personalized Approach to Adverse Drug Reactions
Adverse drug reactions (ADRs) pose a substantial challenge within the pharmaceutical sector, with over 106,000 fatalities annually in the United States, according to…
Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Assessment of the Clinical Validity of Pharmacogenomics in Pain Management.
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a critical public health issue that necessitates…
Lessons from COVID-19: Pharmacogenomics in Preparing for Future Pandemics
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the key to more effective treatments in…
What is “Omics” and is Pharmacogenomics a Part of It?
In the realm of medical research, a novel domain has surfaced – “omics.” It encompasses the in-depth study of biological molecules, including genes,…
PGx and the Microbiome: Understanding How Gut Bacteria Influence Drug Response
Explore the synergy between PGx and the Microbiome to unlock the secrets of gut health’s role in shaping personalized drug responses.
PGx-Guided Antiplatelet Therapy: Reducing Bleeding Risks with Personalized Dosing
Unlock personalized dosing for safer antiplatelet therapy with pharmacogenomics, reducing bleeding risks in cardiovascular care.
The Rise of Polygenic Risk Scores: Can PGx Predict Susceptibility to Medication Side Effects?
Explore how Polygenic Risk Scores enhance personalized medicine by predicting medication side effects and disease susceptibility.
The Importance of Non-Molecular Based Pharmacogenomics Testing
Explore the benefits of Non-Molecular Based Pharmacogenomics Testing for tailored drug therapy that aligns with your unique genetic profile.
End of content
End of content